Products for Out-licensing
Partner with Eurand to expand your product portfolio.
Eurand has a portfolio of Rx and OTC products available for licensing. Eurand applies our drug delivery technologies to products to create new formulations with proven patient benefits.
We license a portfolio of products to pharmaceutical companies for marketing throughout the world. Several of those available for out-licensing are detailed below.
Click here to contact Eurand for more information about licensing opportunities.
| Therapeutic Category |
Product Name | Development Status | Eurand Technology |
|---|---|---|---|
Cardiovascular |
Diltiazem (once daily) Sustained-Release Capsules |
Commercialized; Licensing opportunities available | Diffucaps® |
| Nifedipine (once daily) Sustained-Release Capsules |
Commercialized; Licensing opportunities available | Eurand Minitabs® | |
Sleep Aid |
AdvaTab® Temazepam Orally Disintegrating Tablets |
Formulated (Multiple doses) | AdvaTab® |
| AdvaTab® Diphenhydramine HCl Orally Disintegrating Tablets |
Commercialized; Licensing opportunities available | Microcaps® AdvaTab® |
|
Gastroenterology |
Zenpep® (pancrelipase) Delayed-Release Capsules EUR-1008 (Ex-U.S.) | Commercialized; Licensing opportunities available | Enteric-coated beads |
| Paraffin Oil + Psyllium | Commercialized; Licensing opportunities available | Microcaps® | |
Nutrition |
Vitamin C (once daily) Sustained-Release Capsules Vitamin C / Zinc – Combination Food Product |
Commercialized; Licensing opportunities available | Diffucaps® |
Pain |
Cyclobenzaprine HCl (once daily) Extended-Release Capsules |
Commercialized; Licensing opportunities available | Diffucaps® |
| AdvaTab® Paracetamol (acetaminophen) Orally Disintegrating Tablets |
USP Monograph OTC: Ready to launch | Microcaps® AdvaTab® |
|
| Sodium diclofenac Sustained-Release Capsules |
Commercialized; Licensing opportunities available | Diffucaps® | |
Respiratory |
Theophylline Sustained-Release Capsules |
Commercialized; Licensing opportunities available | Microcaps® |
This information is provided solely for the purpose of the evaluation of business opportunities by potential collaboration partners. The information is based on currently existing data and marketing authorizations in a number of jurisdictions and should not be assumed to be approved by regulatory authorities in any individual country. Consumers should consult with their individual physician for product information and should not rely upon any information provided here.
For more information on these products, please contact Eurand.
Customized Drug Release
Pharmaceutical technologies for formulation development and life cycle management solutions.
Click Now